Par Pharma (PRX) Receives Final Approval to Market Generic Catapres TTS(R); FDA Accepts Application for Miconazole Lauriad(R)
Tweet Send to a Friend
Last night, Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced that its licensing partner, Aveva Drug Delivery Systems, has received final ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
